mRNA |
ifosfamide |
CTRPv2 |
pan-cancer |
AAC |
-0.018 |
0.7 |
mRNA |
Panobinostat |
FIMM |
pan-cancer |
AAC |
0.041 |
0.7 |
mRNA |
navitoclax:pluripotin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.013 |
0.7 |
mRNA |
EHT 1864 |
GDSC1000 |
pan-cancer |
AAC |
-0.012 |
0.7 |
mRNA |
BRD-K30019337 |
CTRPv2 |
pan-cancer |
AAC |
-0.024 |
0.7 |
mRNA |
ABT-888 |
CTRPv2 |
pan-cancer |
AAC |
-0.013 |
0.7 |
mRNA |
Nilotinib |
CCLE |
pan-cancer |
AAC |
0.017 |
0.7 |
mRNA |
NVP-BSK805 |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.7 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.8 |
mRNA |
tubastatin A |
CTRPv2 |
pan-cancer |
AAC |
0.016 |
0.8 |